TP53 and cancer: Such phenomenon has been reported in several cancer types, where a conformational change in p53 enables interaction with new transcription factors, such as p63, p73, NF‐Y, Sp1, NF‐κB, ATM, and SMADS, altering the transcription, cell cycle, apoptosis, and metabolism of cancer cells.36, 37